Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety of Enbrel (etanercept) in rheumatoid
arthritis (RA) subjects with greater than or equal to 1 documented comorbid disease (diabetes
mellitus; chronic pulmonary disease; pneumonia within the last year; or recurrent bronchitis,
sinusitis, or urinary tract infection) that might increase infection risk.